Skip to main content
Premium Trial:

Request an Annual Quote

Bangalore Bioinformatics Firm Licenses Protein Interaction Database to Lion Bioscience Research

NEW YORK, Sept. 17 (GenomeWeb News) – Molecular Connections of Bangalore, India, announced this week that it has licensed its NetPro database of interacting proteins to Lion Bioscience Research.

Financial details of the agreement were not disclosed.

The NetPro database covers more than 30,000 expert curated and annotated protein-protein interactions. All the interactions are from peer-reviewed published scientific literature and have been validated through manual cross-checking, the company said. Molecular Connections will be adding another 30,000 protein databases to NetPro to take the total to 60,000, the company said in an article published by The Economic Times  of India.

Molecular Connections is a joint venture of idea2solutions, an incubator established by the founders of the Hyderabad, India-based pharmaceutical company, Dr. Reddy’s Group, and Singapore-based Institute for Infocomm Research (LabIT).


The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.